The post Dogecoin Rebounds 25% Following Elon Musk’s X Profile Updates as DOGE Price Tests $0.15 Resistance appeared on BitcoinEthereumNews.com. Ted HisokawaThe post Dogecoin Rebounds 25% Following Elon Musk’s X Profile Updates as DOGE Price Tests $0.15 Resistance appeared on BitcoinEthereumNews.com. Ted Hisokawa

Dogecoin Rebounds 25% Following Elon Musk’s X Profile Updates as DOGE Price Tests $0.15 Resistance

For feedback or concerns regarding this content, please contact us at [email protected]


Ted Hisokawa
Jan 04, 2026 20:02

DOGE price climbs to $0.15 with 5.6% daily gains as Elon Musk’s December 31 profile changes continue driving momentum, though technical indicators suggest caution near resistance.

Quick Take

• DOGE trading at $0.15 (up 5.6% in 24h)
• Sustained momentum from Elon Musk’s X profile updates on December 31
• Testing immediate resistance at current levels with RSI approaching overbought
• Bitcoin correlation remains positive as crypto markets extend New Year rally

Market Events Driving Dogecoin Price Movement

The primary catalyst behind Dogecoin’s recent price action stems from Elon Musk’s X profile updates on December 31, 2025, which sparked a remarkable 25% rally that has sustained into early January. The DOGE price opened trading at $0.38 on January 2 before settling at current levels around $0.15, indicating some profit-taking but continued bullish sentiment within the memecoin community.

This latest Musk-driven rally demonstrates the persistent influence of social media catalysts on DOGE price movements. The $790 million in inflows coinciding with the profile updates suggests institutional and retail participants remain highly reactive to Musk’s digital presence, particularly given his historical connection to Dogecoin advocacy.

Prior to this catalyst, Dogecoin technical analysis showed concerning weakness as the token broke down below key exponential moving averages on December 31. However, the Musk effect quickly overshadowed these technical concerns, highlighting how sentiment-driven trading continues to dominate fundamental or technical factors for this particular cryptocurrency.

DOGE Technical Analysis: Testing Upper Resistance Zone

Price Action Context

Dogecoin currently trades above all major short-term moving averages, with the EMA 12 and EMA 26 both sitting at $0.13, providing dynamic support. The DOGE price has effectively reversed the late-December breakdown, though it remains significantly below the 200-day SMA at $0.19, indicating the broader trend remains challenged.

Trading volume of $200 million on Binance spot markets suggests sustained institutional interest, though this represents a cooling from the initial surge. The relationship with Bitcoin remains constructive, with DOGE following the broader cryptocurrency market’s positive momentum into 2026.

Key Technical Indicators

The RSI reading of 63.60 places Dogecoin in neutral territory, though approaching levels that historically precede consolidation phases. The MACD histogram shows a positive 0.0035 reading, confirming bullish momentum remains intact despite the recent pullback from highs.

Most notably, Dogecoin’s Bollinger Bands position reveals the price trading 1.15 standard deviations above the middle band, suggesting the current level represents significant resistance. The Stochastic indicators at 88.15 (%K) and 90.36 (%D) indicate overbought conditions that could limit immediate upside.

Critical Price Levels for Dogecoin Traders

Immediate Levels (24-48 hours)

• Resistance: $0.15 (current level coinciding with upper Bollinger Band)
• Support: $0.13 (convergence of EMA 12/26 and middle Bollinger Band)

Breakout/Breakdown Scenarios

A sustained break above $0.15 resistance could target the stronger resistance zone at $0.17, representing the next significant technical hurdle. However, failure to hold current levels would likely see DOGE price retreat toward the $0.12 support level, where both immediate and strong support converge according to technical analysis.

DOGE Correlation Analysis

• Bitcoin: Following the broader crypto market’s positive sentiment with BTC gains supporting risk appetite for altcoins including DOGE
• Traditional markets: Limited direct correlation observed, though improving risk sentiment in equity markets provides supportive backdrop
• Sector peers: Outperforming most memecoins due to Musk-specific catalyst, though gains have moderated from initial surge

Trading Outlook: Dogecoin Near-Term Prospects

Bullish Case

Sustained momentum requires DOGE price to establish $0.15 as support rather than resistance, potentially opening path toward $0.17. Additional social media catalysts from Musk or broader memecoin adoption could extend the current rally, particularly if Bitcoin maintains its upward trajectory.

Bearish Case

Overbought technical conditions and profit-taking pressure pose immediate risks. A break below $0.13 support would signal the Musk effect has peaked, potentially targeting the $0.12 zone where buyers previously emerged. Broader crypto market weakness could amplify any Dogecoin-specific selling pressure.

Risk Management

Given the elevated volatility, traders should consider stop-losses below $0.13 for long positions while limiting position sizes to account for the 24-hour ATR of $0.01. The sentiment-driven nature of DOGE price movements requires particular attention to social media developments and Musk’s ongoing X activity.

Image source: Shutterstock

Source: https://blockchain.news/news/20260104-dogecoin-rebounds-25-following-elon-musks-x-profile-updates-as

Market Opportunity
Dogelon Mars Logo
Dogelon Mars Price(ELON)
$0.0000000406
$0.0000000406$0.0000000406
+0.02%
USD
Dogelon Mars (ELON) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.
Tags:

You May Also Like

Michael Saylor Pushes Digital Capital Narrative At Bitcoin Treasuries Unconference

Michael Saylor Pushes Digital Capital Narrative At Bitcoin Treasuries Unconference

The post Michael Saylor Pushes Digital Capital Narrative At Bitcoin Treasuries Unconference appeared on BitcoinEthereumNews.com. The suitcoiners are in town.  From a low-key, circular podium in the middle of a lavish New York City event hall, Strategy executive chairman Michael Saylor took the mic and opened the Bitcoin Treasuries Unconference event. He joked awkwardly about the orange ties, dresses, caps and other merch to the (mostly male) audience of who’s-who in the bitcoin treasury company world.  Once he got onto the regular beat, it was much of the same: calm and relaxed, speaking freely and with confidence, his keynote was heavy on the metaphors and larger historical stories. Treasury companies are like Rockefeller’s Standard Oil in its early years, Michael Saylor said: We’ve just discovered crude oil and now we’re making sense of the myriad ways in which we can use it — the automobile revolution and jet fuel is still well ahead of us.  Established, trillion-dollar companies not using AI because of “security concerns” make them slow and stupid — just like companies and individuals rejecting digital assets now make them poor and weak.  “I’d like to think that we understood our business five years ago; we didn’t.”  We went from a defensive investment into bitcoin, Saylor said, to opportunistic, to strategic, and finally transformational; “only then did we realize that we were different.” Michael Saylor: You Come Into My Financial History House?! Jokes aside, Michael Saylor is very welcome to the warm waters of our financial past. He acquitted himself honorably by invoking the British Consol — though mispronouncing it, and misdating it to the 1780s; Pelham’s consolidation of debts happened in the 1750s and perpetual government debt existed well before then — and comparing it to the gold standard and the future of bitcoin. He’s right that Strategy’s STRC product in many ways imitates the consols; irredeemable, perpetual debt, issued at par, with…
Share
BitcoinEthereumNews2025/09/18 02:12
Trump White House Registers Aliens.gov—Is the UFO File Drop Imminent?

Trump White House Registers Aliens.gov—Is the UFO File Drop Imminent?

The post Trump White House Registers Aliens.gov—Is the UFO File Drop Imminent? appeared on BitcoinEthereumNews.com. In brief The White House registered aliens.gov
Share
BitcoinEthereumNews2026/03/19 05:33
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26